Blankart, Carl Rudolf Berchtold

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2008

2018

Blankart, Carl Rudolf Berchtold; Jacobs, Claus Dietrich; Lienhard, Andreas; Ritz, Adrian; Sager, Fritz (eds.) (2018). Schriftenreihe des Kompetenzzentrums für Public Management der Universität Bern (KPM-Schriftenreihe). KPM-Verlag

2017

Varabyova, Yauheniya; Blankart, Carl Rudolf Berchtold; Greer, Ann Lennarson; Schreyögg, Jonas (2017). The determinants of medical technology adoption in different decisional systems: A systematic literature review. Health Policy, 121(3), pp. 230-242. Elsevier 10.1016/j.healthpol.2017.01.005

Hatz, Maximilian H. M.; Schreyögg, Jonas; Torbica, Aleksandra; Boriani, Giuseppe; Blankart, Carl R. B. (2017). Adoption Decisions for Medical Devices in the Field of Cardiology: Results from a European Survey. Health economics, 26(S1), pp. 124-144. Wiley 10.1002/hec.3472

Varabyova, Yauheniya; Blankart, Carl Rudolf; Schreyögg, Jonas (2017). Erratum to: Using nonparametric conditional approach to integrate quality into efficiency analysis: empirical evidence from cardiology departments. Health Care Management Science, 20(4), p. 577. Springer 10.1007/s10729-016-9391-1

Varabyova, Yauheniya; Blankart, Carl Rudolf; Schreyögg, Jonas (2017). The Role of Learning in Health Technology Assessments: An Empirical Assessment of Endovascular Aneurysm Repairs in German Hospitals. Health economics, 26(S1), pp. 93-108. Wiley 10.1002/hec.3466

Varabyova, Yauheniya; Blankart, Carl Rudolf; Torbica, Aleksandra; Schreyögg, Jonas (2017). Comparing the Efficiency of Hospitals in Italy and Germany: Nonparametric Conditional Approach Based on Partial Frontier. Health Care Management Science, 20(3), pp. 379-394. Springer 10.1007/s10729-016-9359-1

Blankart, Carl Rudolf; Stargardt, Tom (2017). Preferred supplier contracts in post-patent prescription drug markets. Health Care Management Science, 20(3), pp. 419-432. Springer 10.1007/s10729-016-9362-6

Hatz, Maximilian H.M.; Sonnenschein, Tim; Blankart, Carl Rudolf (2017). The PMA Scale: A Measure of Physicians’ Motivation to Adopt Medical Devices. Value in health, 20(4), pp. 533-541. Elsevier 10.1016/j.jval.2016.12.002

Varabyova, Yauheniya; Blankart, Carl Rudolf Berchtold; Schreyögg, Jonas (2017). Using nonparametric conditional approach to integrate quality into efficiency analysis: empirical evidence from cardiology departments. Health Care Management Science, 20(4), pp. 565-576. Springer 10.1007/s10729-016-9372-4

2016

Blankart, Carl Rudolf Berchtold; Milstein, Ricarda; Rybczynski, Meike; Schüler, Helke; von Kodolitsch, Yskert (2016). Economic and care considerations of Marfan syndrome. Expert review of pharmacoeconomics & outcomes research, 16(5), pp. 591-598. Taylor & Francis 10.1080/14737167.2016.1240619

Frey, Simon; Blankart, Carl Rudolf; Stargardt, Tom (2016). Economic Burden and Quality-of-Life Effects of Chronic Lymphocytic Leukemia: A Systematic Review of the Literature. PharmacoEconomics, 34(5), pp. 479-498. Adis International / Springer 10.1007/s40273-015-0367-7

Blankart, Carl Rudolf; Emanuel, Ezekiel J.; Bekelman, Justin E. (2016). Characteristics of Patients Dying With Cancer in Developed Countries—Reply. JAMA - the journal of the American Medical Association, 315(24), pp. 2731-2732. American Medical Association 10.1001/jama.2016.4042

Milstein, Ricarda; Blankart, Carl Rudolf (2016). The Health Care Strengthening Act: The next level of integrated care in Germany. Health Policy, 120(5), pp. 445-451. Elsevier 10.1016/j.healthpol.2016.04.006

Bekelman, Justin E.; Halpern, Scott D.; Blankart, Carl Rudolf; Bynum, Julie P.; Cohen, Joachim; Fowler, Robert; Kaasa, Stein; Kwietniewski, Lukas; Melberg, Hans Olav; Onwuteaka-Philipsen, Bregje; Oosterveld-Vlug, Mariska; Pring, Andrew; Schreyögg, Jonas; Ulrich, Connie M.; Verne, Julia; Wunsch, Hannah; Emanuel, Ezekiel J. (2016). Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries. JAMA - the journal of the American Medical Association, 315(3), p. 272. American Medical Association 10.1001/jama.2015.18603

Sachweh, A.; von Kodolitsch, Y.; Kölbel, T.; Larena-Avellaneda, A.; Wipper, S.; Bernhardt, A. M.; Girdauskas, E.; Detter, C.; Reichenspurner, H.; Blankart, Carl Rudolf; Debus, E. S. (2016). I-SWOT als Instrument zur individuell optimierten Therapie bei thorakoabdominalem Aortenaneurysma : effektiv, konform und bedürfnisorientiert. Gefässchirurgie, 21(5), pp. 307-316. Springer-Medizin-Verlag 10.1007/s00772-016-0178-y

2015

Ciani, Oriana; Wilcher, Britni; Blankart, Carl Rudolf Berchtold; Hatz, Maximilian; Rupel, Valentina Prevolnik; Erker, Renata Slabe; Varabyova, Yauheniya; Taylor, Rod S (2015). Health technology assessment of medical devices: a survey of non-European union agencies. International journal of technology assessment in health care, 31(3), pp. 154-165. Cambridge University Press 10.1017/S0266462315000185

von Kodolitsch, Y.; Blankart, Carl Rudolf; Vogler, M.; Kallenbach, K.; Robinson, P. N. (2015). Genetics and prevention of genetic aortic syndromes (GAS) and of the Marfan syndrome. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 58(2), pp. 146-153. Springer-Medizin-Verlag 10.1007/s00103-014-2093-2

2014

Achelrod, Dmitrij; Blankart, Carl Rudolf Berchtold; Linder, Roland; von Kodolitsch, Yskert; Stargardt, Tom (2014). The economic impact of Marfan syndrome: a non-experimental, retrospective, population-based matched cohort study. Orphanet Journal of Rare Diseases, 9(1), p. 90. BioMed Central 10.1186/1750-1172-9-90

2013

Blankart, Carl Rudolf Berchtold; Koch, Taika; Linder, Roland; Verheyen, Frank; Schreyögg, Jonas; Stargardt, Tom (2013). Cost of illness and economic burden of chronic lymphocytic leukemia. Orphanet Journal of Rare Diseases, 8(1), p. 32. BioMed Central 10.1186/1750-1172-8-32

2012

Blankart, Carl Rudolf Berchtold (2012). Does healthcare infrastructure have an impact on delay in diagnosis and survival? Health Policy, 105(2-3), pp. 128-137. Elsevier 10.1016/j.healthpol.2012.01.006

2011

Blankart, Carl Rudolf Berchtold; Stargardt, Tom; Schreyögg, Jonas (2011). Availability of and Access to Orphan Drugs : An International Comparison of Pharmaceutical Treatments for Pulmonary Arterial Hypertension, Fabry Disease, Hereditary Angioedema and Chronic Myeloid Leukaemia. PharmacoEconomics, 29(1), pp. 63-82. Adis International 10.2165/11539190-000000000-00000

2008

Blankart, Carl Rudolf Berchtold; Schreyögg, J; Busse, R (2008). Performance of reimbursement schemes in valuation of technologies: the example of magnetic resonance imaging. Technology and health care : official journal of the European Society for Engineering and Medicine, 16(3), pp. 171-182.

Provide Feedback